Niklas Zennström, co-founder of VC firm Atomico, has stepped down from the board, expressing admiration for Ek's entrepreneurial spirit and the opportunity to work on Neko Health.

An Atomico spokesperson highlighted that it is common for early investors to step aside from the board to accommodate those leading later funding rounds.

Founded in 2018, Neko Health is a preventative healthtech company that specializes in full-body health scans, having opened its first facility in Stockholm in 2023 and scanning over 10,000 individuals since.

The startup has generated significant interest, boasting a waiting list of 100,000 individuals and recently launching operations in London, with plans for further expansion across Europe and the United States.

Neko Health secured initial funding from Atomico, which invested in the company's €60 million Series A round in 2023 and participated in a recent funding round that valued the company at $1.7 billion.

Following Lightspeed's investment in Neko Health's $260 million Series B funding round in January 2025, Bejul Somaia, a partner at Lightspeed, will replace Niklas Zennström on the board.

The current board of Neko Health includes notable figures such as CEO Hjalmar Nilsonne, Daniel Ek, Bejul Somaia, and Klaus Hommels, a partner at Lakestar.